Key points from article :
Big pharma is unwilling to invest in pandemic prevention.
New model could identify and test vaccines at a quicker rate.
Potentially distribute them within weeks.
Model funded by Future Vaccine Manufacturing Hub.
Looking at novel kinds of processing equipment and supply chain strategies.